GeneDx Holdings Corp.
WGS· Nasdaq
WGSGeneDx Holdings Corp.
Filed May 24, 2021 · 10-Q · 54 days after period end · 0001213900-21-028608
| Metric | Q1 2021 | Q1 2020 |
|---|---|---|
| Revenue | $64.20M | $46.66M |
| Net Income | -$191.78M | -$26.99M |
| EPS Diluted | -$348.82 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GeneDx Holdings Corp. · CIK 1818331 · Engraved from SEC EDGAR
ended Mar 31, 2021 · filed May 24, 2021 · 54 d after period end
